methylprednisolone acetate has been researched along with Vitreoretinopathy, Proliferative in 1 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JH | 1 |
| Kim, SJ | 1 |
| Chung, H | 1 |
1 other study available for methylprednisolone acetate and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
The effect of subtenon injection of methylprednisolone acetate on the breakdown of blood retinal barrier after cryotherapy.
Topics: Animals; Anti-Inflammatory Agents; Blood-Retinal Barrier; Capillary Permeability; Cryosurgery; Fasci | 1995 |